This section lists various financial ratios derived from the company's financial statements to help assess its performance and financial health. Below are Current Ratio, Quick Ratio, Debt to Asset Ratio, Return on Equity for ERNAW as of 2026-03-31.
| Financial Ratios | 2026-03-31 | 2025-12-31 |
|---|---|---|
| Return on Equity | -80,274.092 | -146,813.828 |
| Debt to Asset Ratio | 34.943 | 58.845 |
| Quick Ratio | 289.152 | 100.642 |
| Current Ratio | 289.152 | 100.642 |
Ernexa Therapeutics Inc. (ERNAW)
Ernexa Therapeutics Inc. (ERNAW)